Taken together, the results support the hypothesis that TMPRSS2-ETV fusions may be the driving force of the growth-promoting ability of E2-ERβ axis in CRPC cells, suggesting it may contribute to disease progression in PC patients through clonal expansion of castration-resistant phenotype. The gene discussed is ESR2; the disease is pachyonychia congenita.